How are patient-reported outcomes collected and analyzed in blinded studies?

A decentralized, Phase 2, randomized, double-blind study of Nirmatrelvir/Ritonavir compared with placebo/Ritonavir for long COVID. Seizures were controlled in 89% of the episodes treated with lorazepam and in 76% treated with diazepam. The times for onset of action of the medications did ... Aug 23, 1990 ... Phenytoin exerts a beneficial effect by reducing seizures only during the first week after severe head injury. In this short-term study, romiplostim increased platelet counts in 88% of children with ITP and was well-tolerated and apparently safe. Upon receipt of the test material, researchers will record the date of receipt on their copy of DEA Form 222, or attach the documentation to their retained Copy ... A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod (RPC1063) ... ... double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC). Based on the phase 3 KEYNOTE-564 trial ... Jan 22, 2021 ... The aim of this randomized, double-blind phase II/III study was to assess the efficacy of axitinib in patients with advanced G1-2 extra-pancreatic NETs. A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and ... A randomized, double-blind, multicenter study was conducted to investigate the boosting effect. Havrix in 537 healthy adults 18-53 years of age who had ...